Engineered probiotics for tumor-targeted combination chemoimmunotherapy

Zaofeng Yang, Jongwon Im, Noah Chen, Dylan L. Mariuzza, Kenia de los Santos-Alexis, Fangda Li, Edward R. Ballister, Olivia R. Ringham, Tal Danino, Nicholas Arpaia

Open source

DOI
10.1126/scitranslmed.ady2289
Published
2026-09-16
Container
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.ady2289,
  title = {Engineered probiotics for tumor-targeted combination chemoimmunotherapy},
  author = {Zaofeng Yang and Jongwon Im and Noah Chen and Dylan L. Mariuzza and Kenia de los Santos-Alexis and Fangda Li and Edward R. Ballister and Olivia R. Ringham and Tal Danino and Nicholas Arpaia},
  year = {2026},
  journal = {Science Translational Medicine},
  doi = {10.1126/scitranslmed.ady2289},
  url = {https://doi.org/10.1126/scitranslmed.ady2289}
}

RIS

TY  - JOUR
TI  - Engineered probiotics for tumor-targeted combination chemoimmunotherapy
AU  - Zaofeng Yang
AU  - Jongwon Im
AU  - Noah Chen
AU  - Dylan L. Mariuzza
AU  - Kenia de los Santos-Alexis
AU  - Fangda Li
AU  - Edward R. Ballister
AU  - Olivia R. Ringham
AU  - Tal Danino
AU  - Nicholas Arpaia
PY  - 2026
JO  - Science Translational Medicine
DO  - 10.1126/scitranslmed.ady2289
UR  - https://doi.org/10.1126/scitranslmed.ady2289
ER  - 

APA

Yang, Z., Im, J., Chen, N., Mariuzza, D. L., Santos-Alexis, K. D. L., Li, F., Ballister, E. R., Ringham, O. R., Danino, T., & Arpaia, N. (2026). Engineered probiotics for tumor-targeted combination chemoimmunotherapy. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ady2289

Source records